Mary Kay Fenton

Chief Financial OfficeratCullinan Therapeutics· In proxies 2024–2025

Pay in FY2025-50% from the year before · Cullinan Therapeutics stock -15.0% the same year

Mary Kay Fenton was paid $2.1M in FY2025 (Dec), down 50%. Cullinan Therapeutics stock fell 15.0% that year.

Pay$100 in the stock at the end of FY23 → $102

Pay is from the Summary Compensation Table of each Cullinan Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Cullinan TherapeuticsPublic company · 2 yr
- Chief Financial Officer2024 – Present · 2 yrStock in role +62%

Roles come from the proxy statements of each company.

Activity

Pay
Cullinan Therapeutics CFO pay fell 50% to $2.1M. The stock fell 15% in FY2025 (Dec).
DEF 14AApr 28, 2026

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?